blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1696960

EP1696960 - INTRANASAL ADMINISTRATION OF GLUCOSE-REGULATING PEPTIDES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  15.07.2011
Database last updated on 09.04.2026
Most recent event   Tooltip13.09.2013Lapse of the patent in a contracting state
Updated state(s): BG		published on 16.10.2013  [2013/42]
Applicant(s)For all designated states
Amylin Pharmaceuticals, Inc.
9360 Towne Centre Drive
San Diego, CA 92121 / US
[2009/17]
Former [2008/38]For all designated states
MDRNA, Inc.
3830 Monte Villa Parkway
Bothell, WA 98021-7266 / US
Former [2006/52]For all designated states
Nastech Pharmaceutical Company Inc.
3830 Monte Villa Parkway
Bothell, WA 98021-7266 / US
Former [2006/36]For all designated states
Nastech Pharmaceutical Company Inc.
3450 Monte Villa Parkway
Bothell, WA 98021-8906 / US
Inventor(s)01 / QUAY, Steven, C.
23632 HWY 99 STE. F PMB 454
Edmonds, WA 98026-9224 / US
02 / COSTANTINO, Henry, R.
14447 156th Avenue NE
Woodinville, WA 98072 / US
 [2006/36]
Representative(s)MacLean, Martin Robert, et al
Mathys & Squire The Shard
32 London Bridge Street
London SE1 9SG / GB
[N/P]
Former [2006/36]MacLean, Martin Robert, et al
Mathys & Squire 120 Holborn
London EC1N 2SQ / GB
Application number, filing date04815393.617.12.2004
[2006/36]
WO2004US43312
Priority number, dateUS20030532337P26.12.2003         Original published format: US 532337 P
[2006/36]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2005065714
Date:21.07.2005
Language:EN
[2005/29]
Type: A1 Application with search report 
No.:EP1696960
Date:06.09.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 21.07.2005 takes the place of the publication of the European patent application.
[2006/36]
Type: B1 Patent specification 
No.:EP1696960
Date:08.09.2010
Language:EN
[2010/36]
Search report(s)International search report - published on:EP21.07.2005
ClassificationIPC:A61K47/00, A61K9/00
[2006/36]
CPC:
A61K9/0056 (EP,US); A61K47/40 (KR); A61K38/12 (KR);
A61K9/0043 (EP,US); A61K9/0073 (EP,US); A61P3/10 (EP);
A61K38/00 (EP,US); A61K47/10 (EP,US); A61K47/18 (EP,US);
A61K47/24 (EP,US); A61K9/2086 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/36]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
LVNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:INTRANASALE VERABREICHUNG VON GLUCOSE-REGULIERENDEN PEPTIDEN[2006/36]
English:INTRANASAL ADMINISTRATION OF GLUCOSE-REGULATING PEPTIDES[2006/36]
French:ADMINISTRATION INTRANASALE DE PEPTIDES REGULANT LE GLUCOSE[2006/36]
Entry into regional phase26.06.2006National basic fee paid 
26.06.2006Designation fee(s) paid 
26.06.2006Examination fee paid 
Examination procedure26.06.2006Examination requested  [2006/36]
24.08.2006Amendment by applicant (claims and/or description)
25.09.2006Despatch of a communication from the examining division (Time limit: M04)
26.01.2007Reply to a communication from the examining division
04.02.2010Cancellation of oral proceeding that was planned for 09.02.2010
09.02.2010Date of oral proceedings (cancelled)
24.03.2010Communication of intention to grant the patent
23.07.2010Fee for grant paid
23.07.2010Fee for publishing/printing paid
Opposition(s)09.06.2011No opposition filed within time limit [2011/33]
Fees paidRenewal fee
04.12.2006Renewal fee patent year 03
30.11.2007Renewal fee patent year 04
12.12.2008Renewal fee patent year 05
07.12.2009Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT08.09.2010
BE08.09.2010
CY08.09.2010
CZ08.09.2010
DK08.09.2010
EE08.09.2010
FI08.09.2010
LT08.09.2010
NL08.09.2010
PL08.09.2010
RO08.09.2010
SE08.09.2010
SI08.09.2010
SK08.09.2010
TR08.09.2010
BG08.12.2010
GR09.12.2010
IE17.12.2010
LU17.12.2010
CH31.12.2010
LI31.12.2010
MC31.12.2010
IS08.01.2011
PT10.01.2011
HU09.03.2011
[2013/42]
Former [2012/47]AT08.09.2010
BE08.09.2010
BG08.09.2010
CY08.09.2010
CZ08.09.2010
DK08.09.2010
EE08.09.2010
FI08.09.2010
LT08.09.2010
NL08.09.2010
PL08.09.2010
RO08.09.2010
SE08.09.2010
SI08.09.2010
SK08.09.2010
TR08.09.2010
GR09.12.2010
IE17.12.2010
LU17.12.2010
CH31.12.2010
LI31.12.2010
MC31.12.2010
IS08.01.2011
PT10.01.2011
HU09.03.2011
Former [2012/44]AT08.09.2010
BE08.09.2010
BG08.09.2010
CY08.09.2010
CZ08.09.2010
DK08.09.2010
EE08.09.2010
FI08.09.2010
LT08.09.2010
NL08.09.2010
PL08.09.2010
RO08.09.2010
SE08.09.2010
SI08.09.2010
SK08.09.2010
GR09.12.2010
IE17.12.2010
LU17.12.2010
CH31.12.2010
LI31.12.2010
MC31.12.2010
IS08.01.2011
PT10.01.2011
HU09.03.2011
Former [2012/42]AT08.09.2010
BE08.09.2010
BG08.09.2010
CY08.09.2010
CZ08.09.2010
DK08.09.2010
EE08.09.2010
FI08.09.2010
LT08.09.2010
NL08.09.2010
PL08.09.2010
RO08.09.2010
SE08.09.2010
SI08.09.2010
SK08.09.2010
GR09.12.2010
IE17.12.2010
CH31.12.2010
LI31.12.2010
MC31.12.2010
IS08.01.2011
PT10.01.2011
HU09.03.2011
Former [2012/41]AT08.09.2010
BE08.09.2010
BG08.09.2010
CY08.09.2010
CZ08.09.2010
DK08.09.2010
EE08.09.2010
FI08.09.2010
LT08.09.2010
NL08.09.2010
PL08.09.2010
RO08.09.2010
SE08.09.2010
SI08.09.2010
SK08.09.2010
GR09.12.2010
IE17.12.2010
CH31.12.2010
LI31.12.2010
MC31.12.2010
IS08.01.2011
PT10.01.2011
Former [2011/47]AT08.09.2010
BE08.09.2010
CY08.09.2010
CZ08.09.2010
DK08.09.2010
EE08.09.2010
FI08.09.2010
LT08.09.2010
NL08.09.2010
PL08.09.2010
RO08.09.2010
SE08.09.2010
SI08.09.2010
SK08.09.2010
GR09.12.2010
IE17.12.2010
CH31.12.2010
LI31.12.2010
MC31.12.2010
IS08.01.2011
PT10.01.2011
Former [2011/36]AT08.09.2010
BE08.09.2010
CY08.09.2010
CZ08.09.2010
DK08.09.2010
EE08.09.2010
FI08.09.2010
LT08.09.2010
NL08.09.2010
PL08.09.2010
RO08.09.2010
SE08.09.2010
SI08.09.2010
SK08.09.2010
GR09.12.2010
MC31.12.2010
IS08.01.2011
PT10.01.2011
Former [2011/32]AT08.09.2010
BE08.09.2010
CY08.09.2010
CZ08.09.2010
EE08.09.2010
FI08.09.2010
LT08.09.2010
NL08.09.2010
PL08.09.2010
RO08.09.2010
SE08.09.2010
SI08.09.2010
SK08.09.2010
GR09.12.2010
IS08.01.2011
PT10.01.2011
Former [2011/24]AT08.09.2010
CY08.09.2010
CZ08.09.2010
EE08.09.2010
FI08.09.2010
LT08.09.2010
NL08.09.2010
PL08.09.2010
SE08.09.2010
SI08.09.2010
SK08.09.2010
GR09.12.2010
IS08.01.2011
PT10.01.2011
Former [2011/23]AT08.09.2010
CY08.09.2010
CZ08.09.2010
EE08.09.2010
FI08.09.2010
LT08.09.2010
NL08.09.2010
PL08.09.2010
SE08.09.2010
SI08.09.2010
SK08.09.2010
GR09.12.2010
IS08.01.2011
Former [2011/17]AT08.09.2010
CY08.09.2010
FI08.09.2010
LT08.09.2010
NL08.09.2010
PL08.09.2010
SE08.09.2010
SI08.09.2010
GR09.12.2010
Former [2011/15]AT08.09.2010
CY08.09.2010
FI08.09.2010
LT08.09.2010
PL08.09.2010
SE08.09.2010
SI08.09.2010
GR09.12.2010
Former [2011/13]AT08.09.2010
CY08.09.2010
FI08.09.2010
LT08.09.2010
PL08.09.2010
SI08.09.2010
Former [2011/11]AT08.09.2010
FI08.09.2010
LT08.09.2010
PL08.09.2010
SI08.09.2010
Former [2011/08]AT08.09.2010
LT08.09.2010
Cited inby applicant  ENG, J. ET AL., J. BIOL. CHEM., vol. 265, 1990, pages 20259 - 62
   ENG., J. ET AL., J. BIOL. CHEM., vol. 267, 1992, pages 7402 - 05
   GOKE ET AL., J. BIOL. CHEM, vol. 268, 1993, pages 19650 - 55
   ORSKOV ET AL., DIABETES, vol. 42, 1993, pages 658 - 61
   D'ALESSIO ET AL., J. CLIN. INVEST., vol. 97, 1996, pages 133 - 38
   WILLIAMS B ET AL., J CLIN ENCOCRINOL METAB, vol. 81, no. 1, 1996, pages 327 - 32
   WETTERGREN A ET AL., DIG DIS SCI, vol. 38, no. 4, 1993, pages 665 - 73
   SCHJOLDAGER B T ET AL., DIG DIS SCI, vol. 34, no. 5, 1989, pages 703 - 8
   O'HALLORAN D J ET AL., J.ENDOCRINOL, vol. 126, no. 1, 1990, pages 169 - 73
   THORENS, PROC. NATL. ACAD. SCI. USA, vol. 89, 1992, pages 8641 - 45
   SCHMIDT ET AL., DIABETOLOGIA, vol. 28, 1985, pages 704 - 707
   THORTON ET AL., BIOCHEMISTRY, vol. 33, 1994, pages 3532 - 3539
   U.S. PHARMACOPEIA NATIONAL FORMULARY, 1990, pages 1857 - 1859
   FASANO ET AL., PROC. NAT. ACAD. SCI., U.S.A., vol. 8, 1991, pages 5242 - 5246
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.